Living Cell Technologies to reveal clinical trial results
Share
00:30 15 Jun 2015
http://www.*.co.uk/thumbs/upload/News/Image/2016_09/757z468_au_drug_research_350_557e03c35fa6e.jpg
Biotechnology Living Cell Technologies (ASX:LCT) is preparing to divulge clinical trial results.
The company's lead product NTCELL® is an alginate coated capsule containing clusters of neonatal porcine choroid plexus cells.
NTCELL is in Phase I/IIa clinical trial in New Zealand as an advanced therapy for the treatment of Parkinson’s disease.
The ASX has granted the company a trading halt to organise, with the company's shares placed in pre-open.
The halt will remain in place until the opening of trade on Tuesday 16th June 2015, or earlier if an announcement is made to the market.
Living Cell is well-funded with $6.3 million in cash at the end of March 2015.
- Forums
- ASX - By Stock
- 1AI
- Previous Release.
Previous Release.
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 1AI (ASX) to my watchlist
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.81M |
Open | High | Low | Value | Volume |
0.7¢ | 0.8¢ | 0.7¢ | $6.268K | 895.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 4707556 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 1255620 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 4707556 | 0.007 |
9 | 2486749 | 0.006 |
8 | 6510009 | 0.005 |
6 | 7865000 | 0.004 |
1 | 600000 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 1255620 | 12 |
0.009 | 2278303 | 12 |
0.010 | 2350288 | 3 |
0.011 | 1490400 | 3 |
0.012 | 363666 | 3 |
Last trade - 15.50pm 12/09/2024 (20 minute delay) ? |
Featured News
1AI (ASX) Chart |